BioSpace News Archive

Facility producing fiber-based chromatography platform for more efficient biopharmaceutical purification operational in 2019

Increase Separations and Reduce Analysis Times on Any LC Platform

Baxter Ventures leads round to accelerate availability of CleanCision, first-in-class, advanced therapy for surgical patients that fights and defends against the sources of surgical site infection

Cannabics Pharmaceuticals (OTCQB: CNBX), a world leader in personalized cannabinoid medicine focused on cancer and its side effects, today announced that it has filed a provisional patent application with the US Patent office.

Presentations Highlight Commitment to Further ALS Research and Treatment

Declining reimbursement rates is the top industry concern among dentists, according to a 2018 national survey from Bankers Healthcare Group, a leading provider of financial solutions for healthcare professionals.

SpinalCyte, LLC a Texas-based regenerative medicine company focused on regrowth of the spinal disc nucleus using its universal donor product, CybroCell™, today announced the FDA has cleared its Investigational New Drug (IND) protocol for human trials in the U.S., considered to be the first IND approval for a fibroblast cell therapy in a chronic condition outside of dermatological uses.

MiraVista Diagnostics, a developer of diagnostic tests for fungal diseases, announced plans today to expand its operations in central Indiana, creating up to 31 new jobs by 2021.

Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access, today announced the launch of version 2.3 of its Trial Simulator software to help drug developers improve clinical trial design, resulting in greater likelihood of trial success.

On Giving Tuesday, GENYOUth, a public charity committed to improving nutrition, physical activity, and youth leadership in U.S. schools, hosted their annual gala at the Ziegfeld Ballroom in Midtown Manhattan.